Skip to main content

. 1962 Feb;25(1):31–39. doi: 10.1136/jnnp.25.1.31

A MYASTHENIC SYNDROME ASSOCIATED WITH BRONCHIAL CARCINOMA

R P Wise ¹, Violet MacDermot ^1,¹

PMCID: PMC495413 PMID: 14007670

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

ANDERSON H. J., CHURCHILL-DAVIDSON H. C., RICHARDSON A. T. Bronchial neoplasm with myasthenia; prolonged apnoea after administration of succinylcholine. Lancet. 1953 Dec 19;265(6799):1291–1293. doi: 10.1016/s0140-6736(53)91358-0. [DOI] [PubMed] [Google Scholar]
BICKERSTAFF E. R., WOOLF A. L. The intramuscular nerve endings in myasthenia gravis. Brain. 1960 Mar;83:10–23. doi: 10.1093/brain/83.1.10. [DOI] [PubMed] [Google Scholar]
BONDUELLE M., BOUYGUES P., COULON J. Le syndrome myasthénique des polymyosites. Rev Neurol (Paris) 1955;92(6):546–551. [PubMed] [Google Scholar]
BURGEN A. S. V., DICKENS F., ZATMAN L. J. The action of botulinum toxin on the neuro-muscular junction. J Physiol. 1949 Aug;109(1-2):10–24. doi: 10.1113/jphysiol.1949.sp004364. [DOI] [PMC free article] [PubMed] [Google Scholar]
CHURCHILL-DAVIDSON H. C., CHRISTIE T. H. The diagnosis of neuromuscular block in man. Br J Anaesth. 1959 Jul;31:290–301. doi: 10.1093/bja/31.7.290. [DOI] [PubMed] [Google Scholar]
CHURCHILL-DAVIDSON H. C., WISE R. P. Prevention, diagnosis and treatment of prolonged apnoea. Br J Anaesth. 1960 Aug;32:384–387. doi: 10.1093/bja/32.8.384. [DOI] [PubMed] [Google Scholar]
COERS C. The vital staining of muscle biopsies with methylene blue. J Neurol Neurosurg Psychiatry. 1952 Aug;15(3):211–215. doi: 10.1136/jnnp.15.3.211. [DOI] [PMC free article] [PubMed] [Google Scholar]
CROFT P. B. Abnormal responses to muscle relaxants in carcinomatous neuropathy. Br Med J. 1958 Jan 25;1(5064):181–187. doi: 10.1136/bmj.1.5064.181. [DOI] [PMC free article] [PubMed] [Google Scholar]
DESMEDT J. E. Nature of the defect of neuromuscular transmission in myasthenic patients: post-tetanic exhaustion. Nature. 1957 Jan 19;179(4551):156–157. doi: 10.1038/179156a0. [DOI] [PubMed] [Google Scholar]
DOMZALSKI C. A., MORGAN V. C. Dermatomyositis: diagnostic features and therapeutic pitfalls. Am J Med. 1955 Sep;19(3):370–382. doi: 10.1016/0002-9343(55)90126-1. [DOI] [PubMed] [Google Scholar]
EATON L. M., LAMBERT E. H. Electromyography and electric stimulation of nerves in diseases of motor unit; observations on myasthenic syndrome associated with malignant tumors. J Am Med Assoc. 1957 Mar 30;163(13):1117–1124. doi: 10.1001/jama.1957.02970480021005. [DOI] [PubMed] [Google Scholar]
GRAY T. C., HALTON J. Idiosyncrasy to d-tubocurarine chloride. Br Med J. 1948 Apr 24;1(4555):784–786. doi: 10.1136/bmj.1.4555.784. [DOI] [PMC free article] [PubMed] [Google Scholar]
GROB D., HARVEY A. M., JOHNS R. J. Studies in neuromuscular function. II. Effects of nerve stimulation in normal subjects and in patients with myasthenia gravis. Bull Johns Hopkins Hosp. 1956 Sep;99(3):125–135. [PubMed] [Google Scholar]
HEATHFIELD K. W., WILLIAMS J. R. Peripheral neuropathy and myopathy associated with bronchogenic carcinoma. Brain. 1954;77(1):122–137. doi: 10.1093/brain/77.1.122. [DOI] [PubMed] [Google Scholar]
HENSON R. A. Unusual manifestations of bronchial carcinoma. Proc R Soc Med. 1953 Oct;46(10):859–861. [PubMed] [Google Scholar]
MACDERMOT V. The changes in the motor end-plate in myasthenia gravis. Brain. 1960 Mar;83:24–36. doi: 10.1093/brain/83.1.24. [DOI] [PubMed] [Google Scholar]
MASLAND R. L., GAMMON G. D. The effect of botulinus toxin on the electromyogram. J Pharmacol Exp Ther. 1949 Dec;97(4):499–506. [PubMed] [Google Scholar]
MILLIKAN C. H., HAINES S. F. The thyroid gland in relation to neuromuscular disease. AMA Arch Intern Med. 1953 Jul;92(1):5–39. doi: 10.1001/archinte.1953.00240190017002. [DOI] [PubMed] [Google Scholar]
THESLEFF S. A further analysis of the neuromuscular block caused by acetylcholine. Acta Physiol Scand. 1956 Nov 5;37(4):330–334. doi: 10.1111/j.1748-1716.1956.tb01368.x. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES